Phytonutrients in the Treatment of Gastrointestinal Cancer:
Gastrointestinal cancer is one of the most prevalent causes of cancer-related deaths in the world. Recent research demonstrates that phytochemicals are critical in preventing and managing gastrointestinal cancer. The increased intake of phytochemicals could reduce the risk of cancer by inhibiting ca...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Sharjah :
Bentham Science Publishers,
2023.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Gastrointestinal cancer is one of the most prevalent causes of cancer-related deaths in the world. Recent research demonstrates that phytochemicals are critical in preventing and managing gastrointestinal cancer. The increased intake of phytochemicals could reduce the risk of cancer by inhibiting cancer cell proliferation, inducing apoptosis and autophagy, and suppressing angiogenesis as well as cancer cell metastasis. These mechanisms are also known to counte. |
| Beschreibung: | Description based upon print version of record. 3.10. Eugenol |
| Beschreibung: | 1 online resource (309 p.) |
| Bibliographie: | REFERENCES -- FDA Approval for Phytochemicals in the Treatment of Cancer -- Waseem Raza1,3, Jyoti Singh1,3, Yusuf Hussain1,2, Suaib Luqman1,2 and Abha Meena1,2,* -- 1. INTRODUCTION -- 1.1. What is FDA -- 1.2. FDA Principles and Procedures for New Drug Approval -- 1.3. Clinical Phase Trials -- 1.4. Cancer -- 2. FDA APPROVED PHYTOCHEMICALS -- 3. PHYTOCHEMICALS IN CLINICAL TRIALS -- 3.1. Berberine -- 3.2. Curcumin -- 3.3. Epigallocatechin (EGCG) -- 3.4. Isoflavone -- 3.5. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) -- 3.6. Ginseng -- 3.7. Gossypol -- 3.8. Isoquercetin -- 3.9. Cannabinoids |
| ISBN: | 9815049631 9789815049633 |
Internformat
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1382693463 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||||||| | ||
| 008 | 230624s2023 xx o ||| 0 eng d | ||
| 040 | |a EBLCP |b eng |c EBLCP |d N$T |d OCLCO | ||
| 066 | |c (S | ||
| 020 | |a 9815049631 | ||
| 020 | |a 9789815049633 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1382693463 | ||
| 050 | 4 | |a QK861 | |
| 082 | 7 | |a 572.2 |2 23/eng/20230627 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Khan, Haroon. | |
| 245 | 1 | 0 | |a Phytonutrients in the Treatment of Gastrointestinal Cancer |h [electronic resource]. |
| 260 | |a Sharjah : |b Bentham Science Publishers, |c 2023. | ||
| 300 | |a 1 online resource (309 p.) | ||
| 500 | |a Description based upon print version of record. | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Pathophysiology of Gastrointestinal Tract Cancers and Therapeutic Status -- Fatemeh Abbaszadeh1,2,#, Sajad Fakhri3,*, #, Sana Piri3 and Haroon Khan4,* -- 1. INTRODUCTION -- 2. ETIOLOGY AND PATHOLOGY OF GIT CANCERS -- 3. CLASSIFICATIONS OF GASTROINTESTINAL TRACT (GIT) CANCERS -- 3.1. Gastric Cancer (GC) -- 3.2. Esophageal Cancer (EC) -- 3.3. Pancreatic Ductal Adenocarcinoma (PDAC) -- 3.4. Hepatocellular Carcinoma (HCC) -- 3.5. Gallbladder Cancer (GBC) | |
| 505 | 8 | |a ACKNOWLEDGEMENTS -- REFERENCES -- Phytonutrients as a Therapeutic Modality: An Overview -- Marwa A.A. Fayed1, Muhammad Ajmal Shah2,*, Shahid Shah3, Ghulam Mujtaba Shah4, Azhar Rasul5 and Shabnoor Iqbal5 -- 1. INTRODUCTION -- 2. HEALTH BENEFITS OF PHYTONUTRIENTS -- 3. SOURCES OF PHYTONUTRIENTS -- 3.1. Phenolics -- 3.2. Phenolic Acids -- 3.3. Stilbenes -- 3.4. Flavonoids -- 3.5. Terpenoids -- 3.6. Carotenoids -- 3.7. Glucosinolates -- 3.8. Polyacetylenes -- 3.9. Phytosterols -- 3.10. Indigestible Carbohydrates -- 4. PHYTONUTRIENTS-ANTIOXIDANT MECHANISM | |
| 505 | 8 | |a 5. NATURAL PHYTOCHEMICALS USED IN CANCER THERAPY -- 5.1. Phytonutrients and Cancer -- 5.2. Mechanism of Anti-Cancer Phytonutrients -- 5.2.1. Anticancer Phytonutrients can be Classified According to their Mechanism of Action -- 5.3. Some Phytoconstituents and their Role in Treating Cancer -- 5.3.1. Indole-3-Carbinol -- 5.3.2. Curcumin -- 5.3.3. Epigallo-Catechin Gallate -- 5.3.4. Crocin -- 5.3.5. Resveratrol -- 5.3.6. Lycopene -- 5.3.7. Sulforaphane -- 5.3.8. Procyanidins -- 5.3.9. Thymoquinone and Dithymoquinone -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS | |
| 504 | |a REFERENCES -- FDA Approval for Phytochemicals in the Treatment of Cancer -- Waseem Raza1,3, Jyoti Singh1,3, Yusuf Hussain1,2, Suaib Luqman1,2 and Abha Meena1,2,* -- 1. INTRODUCTION -- 1.1. What is FDA -- 1.2. FDA Principles and Procedures for New Drug Approval -- 1.3. Clinical Phase Trials -- 1.4. Cancer -- 2. FDA APPROVED PHYTOCHEMICALS -- 3. PHYTOCHEMICALS IN CLINICAL TRIALS -- 3.1. Berberine -- 3.2. Curcumin -- 3.3. Epigallocatechin (EGCG) -- 3.4. Isoflavone -- 3.5. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) -- 3.6. Ginseng -- 3.7. Gossypol -- 3.8. Isoquercetin -- 3.9. Cannabinoids | ||
| 500 | |a 3.10. Eugenol | ||
| 520 | |a Gastrointestinal cancer is one of the most prevalent causes of cancer-related deaths in the world. Recent research demonstrates that phytochemicals are critical in preventing and managing gastrointestinal cancer. The increased intake of phytochemicals could reduce the risk of cancer by inhibiting cancer cell proliferation, inducing apoptosis and autophagy, and suppressing angiogenesis as well as cancer cell metastasis. These mechanisms are also known to counte. | ||
| 650 | 0 | |a Phytonutrients. |0 http://id.loc.gov/authorities/subjects/sh2011005794 | |
| 650 | 0 | |a Gastrointestinal system |x Cancer |x Treatment. | |
| 650 | 6 | |a Phytonutriments. | |
| 650 | 6 | |a Tractus gastro-intestinal |x Cancer |x Traitement. | |
| 776 | 0 | 8 | |i Print version: |a Khan, Haroon |t Phytonutrients in the Treatment of Gastrointestinal Cancer |d Sharjah : Bentham Science Publishers,c2023 |z 9789815049640 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609419 |3 Volltext |
| 880 | 8 | |6 505-00/(S |a 3.6. Colorectal Cancer (CRC) -- 4. MOLECULAR PATHOLOGY OF GASTROINTESTINAL CANCER -- 4.1. Epidermal Growth Factor Receptor Pathway (EGFR) -- 4.2. Vascular Endothelial Growth Factor Pathway (VEGF) -- 4.3. Wnt/β-catenin Pathway -- 4.4. Insulin-like Growth Factor Receptor (IGFR) Pathway -- 5. MOLECULAR TARGETED THERAPIES IN GASTROINTESTINAL CANCER -- 5.1. Targeting EGFR -- 5.2. Targeting VEGF and VEGFR -- 5.3. Targeting wnt/β-catenin -- 5.4. Targeting IGR-IR -- 5.5. Targeting other Signaling Mediators -- CONCLUSION -- AUTHOR CONTRIBUTIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST | |
| 938 | |a EBSCOhost |b EBSC |n 3609419 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL30593697 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1382693463 |
|---|---|
| _version_ | 1816882570274537472 |
| adam_text | |
| any_adam_object | |
| author | Khan, Haroon |
| author_facet | Khan, Haroon |
| author_role | |
| author_sort | Khan, Haroon |
| author_variant | h k hk |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QK861 |
| callnumber-raw | QK861 |
| callnumber-search | QK861 |
| callnumber-sort | QK 3861 |
| callnumber-subject | QK - Botany |
| collection | ZDB-4-EBA |
| contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Pathophysiology of Gastrointestinal Tract Cancers and Therapeutic Status -- Fatemeh Abbaszadeh1,2,#, Sajad Fakhri3,*, #, Sana Piri3 and Haroon Khan4,* -- 1. INTRODUCTION -- 2. ETIOLOGY AND PATHOLOGY OF GIT CANCERS -- 3. CLASSIFICATIONS OF GASTROINTESTINAL TRACT (GIT) CANCERS -- 3.1. Gastric Cancer (GC) -- 3.2. Esophageal Cancer (EC) -- 3.3. Pancreatic Ductal Adenocarcinoma (PDAC) -- 3.4. Hepatocellular Carcinoma (HCC) -- 3.5. Gallbladder Cancer (GBC) ACKNOWLEDGEMENTS -- REFERENCES -- Phytonutrients as a Therapeutic Modality: An Overview -- Marwa A.A. Fayed1, Muhammad Ajmal Shah2,*, Shahid Shah3, Ghulam Mujtaba Shah4, Azhar Rasul5 and Shabnoor Iqbal5 -- 1. INTRODUCTION -- 2. HEALTH BENEFITS OF PHYTONUTRIENTS -- 3. SOURCES OF PHYTONUTRIENTS -- 3.1. Phenolics -- 3.2. Phenolic Acids -- 3.3. Stilbenes -- 3.4. Flavonoids -- 3.5. Terpenoids -- 3.6. Carotenoids -- 3.7. Glucosinolates -- 3.8. Polyacetylenes -- 3.9. Phytosterols -- 3.10. Indigestible Carbohydrates -- 4. PHYTONUTRIENTS-ANTIOXIDANT MECHANISM 5. NATURAL PHYTOCHEMICALS USED IN CANCER THERAPY -- 5.1. Phytonutrients and Cancer -- 5.2. Mechanism of Anti-Cancer Phytonutrients -- 5.2.1. Anticancer Phytonutrients can be Classified According to their Mechanism of Action -- 5.3. Some Phytoconstituents and their Role in Treating Cancer -- 5.3.1. Indole-3-Carbinol -- 5.3.2. Curcumin -- 5.3.3. Epigallo-Catechin Gallate -- 5.3.4. Crocin -- 5.3.5. Resveratrol -- 5.3.6. Lycopene -- 5.3.7. Sulforaphane -- 5.3.8. Procyanidins -- 5.3.9. Thymoquinone and Dithymoquinone -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS |
| ctrlnum | (OCoLC)1382693463 |
| dewey-full | 572.2 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 572 - Biochemistry |
| dewey-raw | 572.2 |
| dewey-search | 572.2 |
| dewey-sort | 3572.2 |
| dewey-tens | 570 - Biology |
| discipline | Biologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04919cam a2200445Mu 4500</leader><controlfield tag="001">ZDB-4-EBA-on1382693463</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">230624s2023 xx o ||| 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="c">EBLCP</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="066" ind1=" " ind2=" "><subfield code="c">(S</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9815049631</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789815049633</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1382693463</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QK861</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">572.2</subfield><subfield code="2">23/eng/20230627</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Khan, Haroon.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Phytonutrients in the Treatment of Gastrointestinal Cancer</subfield><subfield code="h">[electronic resource].</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Sharjah :</subfield><subfield code="b">Bentham Science Publishers,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (309 p.)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based upon print version of record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Pathophysiology of Gastrointestinal Tract Cancers and Therapeutic Status -- Fatemeh Abbaszadeh1,2,#, Sajad Fakhri3,*, #, Sana Piri3 and Haroon Khan4,* -- 1. INTRODUCTION -- 2. ETIOLOGY AND PATHOLOGY OF GIT CANCERS -- 3. CLASSIFICATIONS OF GASTROINTESTINAL TRACT (GIT) CANCERS -- 3.1. Gastric Cancer (GC) -- 3.2. Esophageal Cancer (EC) -- 3.3. Pancreatic Ductal Adenocarcinoma (PDAC) -- 3.4. Hepatocellular Carcinoma (HCC) -- 3.5. Gallbladder Cancer (GBC)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">ACKNOWLEDGEMENTS -- REFERENCES -- Phytonutrients as a Therapeutic Modality: An Overview -- Marwa A.A. Fayed1, Muhammad Ajmal Shah2,*, Shahid Shah3, Ghulam Mujtaba Shah4, Azhar Rasul5 and Shabnoor Iqbal5 -- 1. INTRODUCTION -- 2. HEALTH BENEFITS OF PHYTONUTRIENTS -- 3. SOURCES OF PHYTONUTRIENTS -- 3.1. Phenolics -- 3.2. Phenolic Acids -- 3.3. Stilbenes -- 3.4. Flavonoids -- 3.5. Terpenoids -- 3.6. Carotenoids -- 3.7. Glucosinolates -- 3.8. Polyacetylenes -- 3.9. Phytosterols -- 3.10. Indigestible Carbohydrates -- 4. PHYTONUTRIENTS-ANTIOXIDANT MECHANISM</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">5. NATURAL PHYTOCHEMICALS USED IN CANCER THERAPY -- 5.1. Phytonutrients and Cancer -- 5.2. Mechanism of Anti-Cancer Phytonutrients -- 5.2.1. Anticancer Phytonutrients can be Classified According to their Mechanism of Action -- 5.3. Some Phytoconstituents and their Role in Treating Cancer -- 5.3.1. Indole-3-Carbinol -- 5.3.2. Curcumin -- 5.3.3. Epigallo-Catechin Gallate -- 5.3.4. Crocin -- 5.3.5. Resveratrol -- 5.3.6. Lycopene -- 5.3.7. Sulforaphane -- 5.3.8. Procyanidins -- 5.3.9. Thymoquinone and Dithymoquinone -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">REFERENCES -- FDA Approval for Phytochemicals in the Treatment of Cancer -- Waseem Raza1,3, Jyoti Singh1,3, Yusuf Hussain1,2, Suaib Luqman1,2 and Abha Meena1,2,* -- 1. INTRODUCTION -- 1.1. What is FDA -- 1.2. FDA Principles and Procedures for New Drug Approval -- 1.3. Clinical Phase Trials -- 1.4. Cancer -- 2. FDA APPROVED PHYTOCHEMICALS -- 3. PHYTOCHEMICALS IN CLINICAL TRIALS -- 3.1. Berberine -- 3.2. Curcumin -- 3.3. Epigallocatechin (EGCG) -- 3.4. Isoflavone -- 3.5. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) -- 3.6. Ginseng -- 3.7. Gossypol -- 3.8. Isoquercetin -- 3.9. Cannabinoids</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">3.10. Eugenol</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gastrointestinal cancer is one of the most prevalent causes of cancer-related deaths in the world. Recent research demonstrates that phytochemicals are critical in preventing and managing gastrointestinal cancer. The increased intake of phytochemicals could reduce the risk of cancer by inhibiting cancer cell proliferation, inducing apoptosis and autophagy, and suppressing angiogenesis as well as cancer cell metastasis. These mechanisms are also known to counte.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Phytonutrients.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh2011005794</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Gastrointestinal system</subfield><subfield code="x">Cancer</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Phytonutriments.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tractus gastro-intestinal</subfield><subfield code="x">Cancer</subfield><subfield code="x">Traitement.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Khan, Haroon</subfield><subfield code="t">Phytonutrients in the Treatment of Gastrointestinal Cancer</subfield><subfield code="d">Sharjah : Bentham Science Publishers,c2023</subfield><subfield code="z">9789815049640</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609419</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="880" ind1="8" ind2=" "><subfield code="6">505-00/(S</subfield><subfield code="a">3.6. Colorectal Cancer (CRC) -- 4. MOLECULAR PATHOLOGY OF GASTROINTESTINAL CANCER -- 4.1. Epidermal Growth Factor Receptor Pathway (EGFR) -- 4.2. Vascular Endothelial Growth Factor Pathway (VEGF) -- 4.3. Wnt/β-catenin Pathway -- 4.4. Insulin-like Growth Factor Receptor (IGFR) Pathway -- 5. MOLECULAR TARGETED THERAPIES IN GASTROINTESTINAL CANCER -- 5.1. Targeting EGFR -- 5.2. Targeting VEGF and VEGFR -- 5.3. Targeting wnt/β-catenin -- 5.4. Targeting IGR-IR -- 5.5. Targeting other Signaling Mediators -- CONCLUSION -- AUTHOR CONTRIBUTIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3609419</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL30593697</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1382693463 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:30:43Z |
| institution | BVB |
| isbn | 9815049631 9789815049633 |
| language | English |
| oclc_num | 1382693463 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (309 p.) |
| psigel | ZDB-4-EBA |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Bentham Science Publishers, |
| record_format | marc |
| spelling | Khan, Haroon. Phytonutrients in the Treatment of Gastrointestinal Cancer [electronic resource]. Sharjah : Bentham Science Publishers, 2023. 1 online resource (309 p.) Description based upon print version of record. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Pathophysiology of Gastrointestinal Tract Cancers and Therapeutic Status -- Fatemeh Abbaszadeh1,2,#, Sajad Fakhri3,*, #, Sana Piri3 and Haroon Khan4,* -- 1. INTRODUCTION -- 2. ETIOLOGY AND PATHOLOGY OF GIT CANCERS -- 3. CLASSIFICATIONS OF GASTROINTESTINAL TRACT (GIT) CANCERS -- 3.1. Gastric Cancer (GC) -- 3.2. Esophageal Cancer (EC) -- 3.3. Pancreatic Ductal Adenocarcinoma (PDAC) -- 3.4. Hepatocellular Carcinoma (HCC) -- 3.5. Gallbladder Cancer (GBC) ACKNOWLEDGEMENTS -- REFERENCES -- Phytonutrients as a Therapeutic Modality: An Overview -- Marwa A.A. Fayed1, Muhammad Ajmal Shah2,*, Shahid Shah3, Ghulam Mujtaba Shah4, Azhar Rasul5 and Shabnoor Iqbal5 -- 1. INTRODUCTION -- 2. HEALTH BENEFITS OF PHYTONUTRIENTS -- 3. SOURCES OF PHYTONUTRIENTS -- 3.1. Phenolics -- 3.2. Phenolic Acids -- 3.3. Stilbenes -- 3.4. Flavonoids -- 3.5. Terpenoids -- 3.6. Carotenoids -- 3.7. Glucosinolates -- 3.8. Polyacetylenes -- 3.9. Phytosterols -- 3.10. Indigestible Carbohydrates -- 4. PHYTONUTRIENTS-ANTIOXIDANT MECHANISM 5. NATURAL PHYTOCHEMICALS USED IN CANCER THERAPY -- 5.1. Phytonutrients and Cancer -- 5.2. Mechanism of Anti-Cancer Phytonutrients -- 5.2.1. Anticancer Phytonutrients can be Classified According to their Mechanism of Action -- 5.3. Some Phytoconstituents and their Role in Treating Cancer -- 5.3.1. Indole-3-Carbinol -- 5.3.2. Curcumin -- 5.3.3. Epigallo-Catechin Gallate -- 5.3.4. Crocin -- 5.3.5. Resveratrol -- 5.3.6. Lycopene -- 5.3.7. Sulforaphane -- 5.3.8. Procyanidins -- 5.3.9. Thymoquinone and Dithymoquinone -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS REFERENCES -- FDA Approval for Phytochemicals in the Treatment of Cancer -- Waseem Raza1,3, Jyoti Singh1,3, Yusuf Hussain1,2, Suaib Luqman1,2 and Abha Meena1,2,* -- 1. INTRODUCTION -- 1.1. What is FDA -- 1.2. FDA Principles and Procedures for New Drug Approval -- 1.3. Clinical Phase Trials -- 1.4. Cancer -- 2. FDA APPROVED PHYTOCHEMICALS -- 3. PHYTOCHEMICALS IN CLINICAL TRIALS -- 3.1. Berberine -- 3.2. Curcumin -- 3.3. Epigallocatechin (EGCG) -- 3.4. Isoflavone -- 3.5. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) -- 3.6. Ginseng -- 3.7. Gossypol -- 3.8. Isoquercetin -- 3.9. Cannabinoids 3.10. Eugenol Gastrointestinal cancer is one of the most prevalent causes of cancer-related deaths in the world. Recent research demonstrates that phytochemicals are critical in preventing and managing gastrointestinal cancer. The increased intake of phytochemicals could reduce the risk of cancer by inhibiting cancer cell proliferation, inducing apoptosis and autophagy, and suppressing angiogenesis as well as cancer cell metastasis. These mechanisms are also known to counte. Phytonutrients. http://id.loc.gov/authorities/subjects/sh2011005794 Gastrointestinal system Cancer Treatment. Phytonutriments. Tractus gastro-intestinal Cancer Traitement. Print version: Khan, Haroon Phytonutrients in the Treatment of Gastrointestinal Cancer Sharjah : Bentham Science Publishers,c2023 9789815049640 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609419 Volltext 505-00/(S 3.6. Colorectal Cancer (CRC) -- 4. MOLECULAR PATHOLOGY OF GASTROINTESTINAL CANCER -- 4.1. Epidermal Growth Factor Receptor Pathway (EGFR) -- 4.2. Vascular Endothelial Growth Factor Pathway (VEGF) -- 4.3. Wnt/β-catenin Pathway -- 4.4. Insulin-like Growth Factor Receptor (IGFR) Pathway -- 5. MOLECULAR TARGETED THERAPIES IN GASTROINTESTINAL CANCER -- 5.1. Targeting EGFR -- 5.2. Targeting VEGF and VEGFR -- 5.3. Targeting wnt/β-catenin -- 5.4. Targeting IGR-IR -- 5.5. Targeting other Signaling Mediators -- CONCLUSION -- AUTHOR CONTRIBUTIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST |
| spellingShingle | Khan, Haroon Phytonutrients in the Treatment of Gastrointestinal Cancer Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Pathophysiology of Gastrointestinal Tract Cancers and Therapeutic Status -- Fatemeh Abbaszadeh1,2,#, Sajad Fakhri3,*, #, Sana Piri3 and Haroon Khan4,* -- 1. INTRODUCTION -- 2. ETIOLOGY AND PATHOLOGY OF GIT CANCERS -- 3. CLASSIFICATIONS OF GASTROINTESTINAL TRACT (GIT) CANCERS -- 3.1. Gastric Cancer (GC) -- 3.2. Esophageal Cancer (EC) -- 3.3. Pancreatic Ductal Adenocarcinoma (PDAC) -- 3.4. Hepatocellular Carcinoma (HCC) -- 3.5. Gallbladder Cancer (GBC) ACKNOWLEDGEMENTS -- REFERENCES -- Phytonutrients as a Therapeutic Modality: An Overview -- Marwa A.A. Fayed1, Muhammad Ajmal Shah2,*, Shahid Shah3, Ghulam Mujtaba Shah4, Azhar Rasul5 and Shabnoor Iqbal5 -- 1. INTRODUCTION -- 2. HEALTH BENEFITS OF PHYTONUTRIENTS -- 3. SOURCES OF PHYTONUTRIENTS -- 3.1. Phenolics -- 3.2. Phenolic Acids -- 3.3. Stilbenes -- 3.4. Flavonoids -- 3.5. Terpenoids -- 3.6. Carotenoids -- 3.7. Glucosinolates -- 3.8. Polyacetylenes -- 3.9. Phytosterols -- 3.10. Indigestible Carbohydrates -- 4. PHYTONUTRIENTS-ANTIOXIDANT MECHANISM 5. NATURAL PHYTOCHEMICALS USED IN CANCER THERAPY -- 5.1. Phytonutrients and Cancer -- 5.2. Mechanism of Anti-Cancer Phytonutrients -- 5.2.1. Anticancer Phytonutrients can be Classified According to their Mechanism of Action -- 5.3. Some Phytoconstituents and their Role in Treating Cancer -- 5.3.1. Indole-3-Carbinol -- 5.3.2. Curcumin -- 5.3.3. Epigallo-Catechin Gallate -- 5.3.4. Crocin -- 5.3.5. Resveratrol -- 5.3.6. Lycopene -- 5.3.7. Sulforaphane -- 5.3.8. Procyanidins -- 5.3.9. Thymoquinone and Dithymoquinone -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS Phytonutrients. http://id.loc.gov/authorities/subjects/sh2011005794 Gastrointestinal system Cancer Treatment. Phytonutriments. Tractus gastro-intestinal Cancer Traitement. |
| subject_GND | http://id.loc.gov/authorities/subjects/sh2011005794 |
| title | Phytonutrients in the Treatment of Gastrointestinal Cancer |
| title_auth | Phytonutrients in the Treatment of Gastrointestinal Cancer |
| title_exact_search | Phytonutrients in the Treatment of Gastrointestinal Cancer |
| title_full | Phytonutrients in the Treatment of Gastrointestinal Cancer [electronic resource]. |
| title_fullStr | Phytonutrients in the Treatment of Gastrointestinal Cancer [electronic resource]. |
| title_full_unstemmed | Phytonutrients in the Treatment of Gastrointestinal Cancer [electronic resource]. |
| title_short | Phytonutrients in the Treatment of Gastrointestinal Cancer |
| title_sort | phytonutrients in the treatment of gastrointestinal cancer |
| topic | Phytonutrients. http://id.loc.gov/authorities/subjects/sh2011005794 Gastrointestinal system Cancer Treatment. Phytonutriments. Tractus gastro-intestinal Cancer Traitement. |
| topic_facet | Phytonutrients. Gastrointestinal system Cancer Treatment. Phytonutriments. Tractus gastro-intestinal Cancer Traitement. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609419 |
| work_keys_str_mv | AT khanharoon phytonutrientsinthetreatmentofgastrointestinalcancer |